ST
ALDR

Spot Trading’s Alder Biopharmaceuticals ALDR Stock Holding History

Spot Trading’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-5,900
Closed -$193K – 4276
2015
Q3 		$193K Buy
+5,900
New +$251K ﹤0.01% 2710

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Spot Trading's ALDR Position: Q4 2015 in Review

Spot Trading sold out of Alder Biopharmaceuticals (ALDR) in Q4 2015, closing a stake of 1,066 shares — an estimated $35K sold.

Spot Trading first reported a position in ALDR in Q3 2015 and held it in 1 quarter. The position peaked at $35K in Q3 2015. 134 funds tracked by Wall St. Rank hold ALDR as of Q4 2015.

  • Spot Trading reported no remaining Alder Biopharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Spot Trading sold 1,066 Alder Biopharmaceuticals shares in Q4 2015, an estimated $35K.
  • Spot Trading first reported a position in Alder Biopharmaceuticals in Q3 2015 and held it in 1 quarter.
  • Spot Trading's Alder Biopharmaceuticals position peaked at $35K in Q3 2015.
  • 134 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2015.

Based on Spot Trading's 13F filing for Q4 2015, filed 29 Jan 2016.